Medical Weight Loss Eligibility Consultation
Request an eligibility consultation with Sarasota Trim Clinic and learn what to expect during the evaluation. A licensed provider determines eligibility — not a website quiz. Use the consultation form below to start that conversation.
General Eligibility Considerations
Medical weight loss programs, including GLP-1 therapy, are generally appropriate for adults who meet certain clinical criteria. The following reflects general considerations — your provider makes the actual determination based on your individual health profile.
May Be a Good Fit
- •Adults 18 and older
- •BMI of 30 or higher, or BMI 27+ with a weight-related health condition
- •Prior difficulty achieving or sustaining weight loss through diet and exercise alone
- •Interest in medically guided support
- •Florida residency (required for telehealth prescription)
- •No contraindications to GLP-1 medications (assessed by provider)
May Not Be a Good Fit
- •Personal or family history of medullary thyroid carcinoma
- •History of Multiple Endocrine Neoplasia syndrome type 2
- •Pregnancy or planned pregnancy
- •Active pancreatitis
- •Severe gallbladder disease
- •Certain other conditions — your provider will assess fully
This is educational information, not a medical determination. Whether GLP-1 medications are appropriate for you is a clinical decision made by a licensed provider based on your complete health profile and medical history.
What Happens During the Eligibility Evaluation
During your free consultation, a licensed provider will ask about:
The consultation is your opportunity to ask questions too. Your provider will be straightforward — if you're not a candidate for medication, they'll tell you and explain why.
Request a Consultation
The only way to know if you're eligible is to speak with a licensed provider. Fill out the form below to request a callback, or book directly online.
Or book directly: Schedule Online · 239-422-6350
Important Safety Reminder
GLP-1 medications carry real risks, including nausea, vomiting, pancreatitis, and rare but serious complications. This page is educational and does not constitute a medical evaluation. Your provider will discuss all relevant risks and contraindications based on your personal health history. If you experience a medical emergency, call 911 immediately.
MEDICAL SOURCES & FURTHER READING
These sources address the topics identified below. They provide general education, not individualized medical advice, a clinic endorsement or a prediction of your results. Prescription treatment requires evaluation by a licensed provider; eligibility, medication and dosing depend on individual circumstances.
NIH — National Institute of Diabetes and Digestive and Kidney Diseases
Prescription Medications to Treat Overweight & ObesityWeight-management medication eligibility, appetite, lifestyle support and individualized treatment decisions.
U.S. Food and Drug Administration
Wegovy prescribing information and Medication Guide (PDF)Semaglutide indications, mechanism, contraindications, thyroid warning, pancreatitis, pregnancy and adverse reactions; this label does not apply to compounded products.
U.S. Food and Drug Administration
Zepbound prescribing information and Medication Guide (PDF)Tirzepatide indications, dual GIP/GLP-1 mechanism, contraindications and adverse reactions; this label does not apply to compounded products.